Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[18F]-Fludarabine PET/MR imaging in newly diagnosed primary CNS lymphoma
2021-005193-26Phase 2Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Nov 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of fludarabine in primary central nervous system lymphoma (PCNSL), sponsored by Assistance publique - Hôpitaux de Paris. Started Nov 2021; status: active.
02
Drugs
fludarabine
03
Conditions
primary central nervous system lymphoma (PCNSL)
Beyond the preview
Go deeper on 2021-005193-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-005193-26.